lenvatinib和everimous结合治疗晚期或转移性肾癌患者的建议

IF 0.1 Q4 ONCOLOGY

Onkourologiya Pub Date : 2021-02-09 DOI:10.17650/1726-9776-2020-16-4-61-81

Enrique Grande, Н. Glen, J. Aller, G. Argenziano, M. J. Lamas, P. Ruszniewski, J. Zamorano, K. Edmonds, S. Sarker, Michael Staehler, J. Larkin

引用次数: 5

摘要

．

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Рекомендации по лечению пациентов с прогрессирующим или метастатическим почечно-клеточным раком комбинацией ленватиниба и эверолимуса

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Onkourologiya ONCOLOGY-

CiteScore

0.40

自引率

0.00%

发文量

审稿时长

10 weeks

期刊介绍： The main objective of the journal "Cancer urology" is publishing up-to-date information about scientific clinical researches, diagnostics, treatment of oncologic urological diseases. The aim of the edition is to inform the experts on oncologic urology about achievements in this area, to build understanding of the necessary integrated interdisciplinary approach in therapy, alongside with urologists, combining efforts of doctors of various specialties (cardiologists, pediatricians, chemotherapeutists et al.), to contribute to raising the effectiveness of oncologic patients’ treatment.